RecruitingNCT05243966

Myriad™ Augmented Soft Tissue Reconstruction Registry

Studying Anal fistula

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Aroa Biosurgery Limited
Principal Investigator: Tracee Short, MD
Short Consulting Group, LLC
Intervention: Myriad Matrix™ and Myriad Morcells™(device)
Enrollment: 800 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2029

Study locations (13)

Surgery Group LA, Los Angeles, California, United States
Associates in Medicine & Surgery, Fort Myers, Florida, United States
Asencion Sacred Heart, Pensacola, Florida, United States
Northeast Georgia Medical Center, Inc., Gainesville, Georgia, United States
University Medical Center, New Orleans, Louisiana, United States
Ochsner Baptist Medical Center, New Orleans, Louisiana, United States
Sinai Hospital of Baltimore, Baltimore, Maryland, United States
Nuvance Health Vassar Brothers Medical Center, Poughkeepsie, New York, United States
Moses H Cone Memorial Hospital Operating Corporation, Greensboro, North Carolina, United States
Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Lancaster General Hospital, Lancaster, Pennsylvania, United States
Tower Health Reading Hospital, West Reading, Pennsylvania, United States
The Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05243966 on ClinicalTrials.gov

Other trials for Anal fistula

Additional recruiting or active studies for the same condition.

See all trials for Anal fistula →

← Back to all trials